Investival Showcase

🚀 Medtech & Digital Health Leaders: Hit regulatory milestones to significantly enhance investor confidence💡 Are you navigating the complex intersection of regulatory approvals and funding in the medtech or digital health space? Don't miss this game-changing panel at Investival Showcase USA 2025! "The Impact of Regulatory Approvals on Funding and Investment in Medtech and Digital Health" Join our panel of experts: • Viral Gandhi, Principal, KCK Medtech • Darshana Zaveri, Managing Partner, CHV • Giles Hamilton, Operating Partner, New Growth Advisors Discover: ✅ How regulatory milestones can skyrocket investor confidence ✅ Strategies to align your funding efforts with regulatory progress ✅ Real-world success stories: When regulations meet investments 🗓️ March 10-11, 2025 📍 Miami - Where Innovation Meets Opportunity! Ready to optimize your funding prospects? Learn how to leverage regulatory success to fuel your company's growth and attract investors! Register now: https://lnkd.in/eUnJhpfJ #investivalusa #medicaltechnology #Medtech #DigitalHealth #Healthtech #MedtechFunding #DigitalHealthInvestment Who's joining me at this must-attend event for medtech and digital health innovators? Let's connect and discuss how regulatory milestones are shaping your investment journey! 🤝

🚀 Biotech Leaders: Ready to Scale Up Your Fundraising?💰 Are you a biotech startup that's conquered Series A and now eyeing the next big leap? Don't miss this game-changing panel at the Investival Showcase USA 2025! "Scaling Up: Strategies for Successful Post-Series A Fundraising" Unlock the secrets to navigating the complex world of later-stage funding with our expert panel: • J.C. Lopez, Principal, New Enterprise Associates (NEA) • Maite Malet, Investment & Corporate Development, Asabys Partners • Sourav Sinha, Partner, Bedford Bridge Dive deep into: ✅ Approaching later-stage investors: What's new after Series A? ✅ Preparing for larger funding rounds ✅ Managing evolving investor expectations ✅ Avoiding common pitfalls as you scale 🗓️ March 10-11, 2025 📍 Miami - Where Sun, Sand, and Startups Converge! Don't let your biotech dream stall after Series A. Arm yourself with the knowledge to secure your next round! Register now: https://lnkd.in/eUnJhpfJ #investivalusa #biotechnology #biotech #biopharma #biotechleaders #BiotechFunding #BiopharmaInnovation Who's joining me at this must-attend event for biotech leaders? Let's connect and discuss your fundraising journey! 🤝

🧬 Biotech Founders & Investors: Don't Miss This Panel! Unlocking Value in Early-Stage Biotech: Navigating the Pre-Clinical Valuation Puzzle Are you grappling with the challenges of valuing pre-clinical assets? Join us for an insightful discussion that could revolutionize your approach to biotech valuation and investment! 🔍 Key Focus Areas: • Scientific risk assessment and its impact on valuation • Building value through strategic partnerships and milestones • Market potential and competitive landscape analysis 🎙️ Expert Panelists: • Emily P., Principal, DCVC Bio • Reetika B., Senior Associate, ARCH Venture Partners • Fabio Pucci, Senior Director, Venture Investments, Leaps by Bayer These seasoned investors will share their invaluable insights on: ✅ How investors assess the potential of early-stage biotech assets ✅ Key drivers of valuation in the pre-clinical stage ✅ Strategies for attracting investment despite high scientific uncertainty 🗓️ March 10-11, 2025 📍 Miami - Sun, Sand, and Startups Ready to unlock the secrets of early-stage biotech valuation? Register now! 🔗 https://lnkd.in/eUnJhpfJ #InvestivalUSA #Biotechnology #biotech #biopharma #biotechleaders #BiotechInvestment #PreclinicalValuation #VentureCapital #BiopharmaInnovation Who's joining us in Miami? Tag a biotech founder or investor who needs to be there! 👇

Medtech Leaders Spotlight: Meet Cody Simmons, CEO of DermaSensor Cody is a bioengineer and entrepreneur that has focused all of his career on bringing new health technologies to physicians and patients. Most recently he led commercial efforts for a Silicon Valley medical device screening startup and held BD and commercial strategy roles at Genentech. We kept it simple and asked Cody: How is your company making a difference? DermaSensor, Inc. was developed to address two significant challenges in healthcare: the challenges that primary care providers have in effectively managing suspicious lesions and the poor compliance and access for patients seeing dermatologists who are at risk for skin cancer.   Firstly, primary care physicians often lack the necessary tools and training to accurately identify skin lesions indicative of cancer. This leads to missed diagnoses, delayed treatment, and poorer outcomes for patients. With melanoma projected to become the second most common cancer by 2040, early detection is crucial.   Secondly, there is a shortage of dermatologists, leading to lengthy appointment wait times. Patients often have to wait months before seeing a specialist for a skin examination. This delay can result in anxiety for patients awaiting a diagnosis and can exacerbate the progression of potentially deadly skin conditions.   DermaSensor's creation represents a breakthrough approach to improving skin care in America by enabling patients with access to prompt detection and timely management of skin cancer by physicians. Cody will be presenting at the Investival Showcase USA. 🗓️ March 10-11, 2025 📍 Miami - Innovation in Paradise! 🌴 Learn more and register: https://lnkd.in/eUnJhpfJ #investivalusa #medtech #medicaldevices #medicaldevice #medicaltechnology

Biotech, medtech and healthtech companies share the same simple mission – to revolutionise healthcare. Unfortunately, simple doesn’t mean easy! Groundbreaking innovation requires more than just vision—it demands significant investment and strategic partnerships. That's where Investival Showcase comes in. 🤝 We're bridging the gap between visionary innovators and the investors and partners they need to fuel healthcare's future. Mark your calendars: 🗓️ March 10-11, 2025 📍 Miami - Sun, Sand, and Startups Learn more and register: https://lnkd.in/eUnJhpfJ Whether you're an innovator or investor, you'll find the partners you need at the Investival Showcase USA. See you there! 🌴 Informa Connect Life Sciences LSX - partnering for Life Science eXecutives BioXconomy Ford Hutman Media KKH Advisors #investivalusa #biotechnology #biotech #biopharma #medicaldevices #medtech #healthtech #healthtechnology #digitalhealth #telemedicine

🔍 Digital Health and MedTech: How to work with CVCs Join us to explore what CVCs want, and how they align with medtech and digital health M&A and BD. 🧠 Key themes:  • CVC Priorities: Balancing strategic alignment with financial returns • Synergies between CVC investments and M&A activities • Collaboration between CVCs and Business Development teams 🎙️Hear from: • Katerina Fialkovskaya, Investment Director, Philips Ventures, Philips • Murielle Thinard McLane, President & Managing Partner, Intuitive Ventures • Jonathan Machado, Managing Director, Samsung Next • Jeff Weness, Head of Digital Investments, Otsuka Precision Health, Inc. (OPH) 🗓️ March 10-11, 2025 📍 Miami - Innovation in Paradise! 🌴 Learn more and register: https://lnkd.in/eUnJhpfJ See you there! 🌞 #investivalusa #medtech #medicaldevices #healthtech #digitalhealth

Biotech Leaders Spotlight: Meet Andy Parker, CEO of Step Pharma Andy has been leading Step Pharma for the past five years. With over two decades of experience spanning pharmaceutical, biotechnology, and venture capital sectors, Andy brings a wealth of knowledge to the forefront of innovative cancer treatments. We caught up with Andy to share some insights into Step Pharma's groundbreaking work. What are your company's primary objectives for the next 1-3 years? Step Pharma will continue to expand it’s clinical activity with dencatistat, our first in class CTPS1 inhibitor, a precision oncology drug, to maximise the benefit to patients across multiple indications. In T and B cell lymphoma where we treat all comers, we expect to enter PhII in 2025. In solid tumours we exploit a synthetic lethal strategy selecting patients for loss of CTPS2, exposing a dependence on CTPS1. This represents a pan-cancer opportunity for solid tumours. The assay is validated for ovarian cancer (biomarker prevalence 20%) and is undergoing validation for several other solid tumour types including NSCLC. We expect to complete PoC studies in ovarian and one or more other solid tumour types in the next 12 months. Are there any significant milestones or launch dates we should be aware of? In essential thrombocythemia we have just started the PhIb study and expect this study to demonstrate PoC in 2025. Our clinical activities will significantly ramp up in 2025 and continue to expand through 2026 onwards necessitating an increase in personnel particularly across clinical operations and CMC. Which markets or regions will be the focus of your future expansion or growth efforts? All our studies are being executed across US, UK and EU. We will also explore options for clinical development in other geographies either directly or via regional partnerships. Consequently, we also expect to increase our Business Development capabilities as we seek partnerships to maximise the clinical development opportunities for dencatistat. Andy will be presenting at the Investival Showcase USA. 🗓️ March 10-11, 2025 📍 Miami - Sun, Sand, and Startups Discover more about Step Pharma's innovative approach to precision oncology and cancer treatment. Learn more and register: https://lnkd.in/eUnJhpfJ #investivalusa #biotechnology #biotech #biopharma #biotechleaders #CTPS1 #oncology #drugdiscovery

🌊 Ride the Wave of Healthcare Investment in 2025 Join us to explore the current state of healthcare investments and deal-making in 2025, expectations for the rest of the year, and insights into how companies can successfully navigate these dynamic waters. 🎙️Hear from: • Christian R. Schubert, VP & Head, AbbVie Ventures, AbbVie • Andrew W. Lam, PharmD, Managing Director, Head of Biotech Private Equity, Ally Bridge Group • Maha Radhakrishnan, Executive Partner, Sofinnova Investments • Evan Rachlin, Co-Founder & Managing Partner, Ascenta Capital 🧠 Key themes:  • Decoding the key factors driving investment • Exploring the role of collaborations • Comparing the US healthcare investment landscape to global trends 🗓️ March 10-11, 2025 📍 Miami - Sun, Sand, and Startups Learn more and register: https://lnkd.in/eUnJhpfJ See you there! 🌴 #investivalusa #biotechnology #biopharma #medicaldevices #digitalhealth

🎉 Black Friday Prize Draw Winners Announced! 🏆 We're thrilled to reveal the winners of our exclusive Black Friday Prize Draw, who've won a pitch and partner showcase presentation at the Investival Showcase USA, March 10-11 at the Miami Beach Convention Center. 🔬 Biotech Showcase Winner: Step Pharma 🩺 Medtech & Digital Health Showcase Winner: DermaSensor, Inc. 🌴 Join them in Miami for: • Inspiring pitches from biotech, medtech and digital health stars • Networking opportunities with industry leaders • Insights into the latest trends shaping life science innovation Learn more and secure your spot: 👉 https://lnkd.in/eUnJhpfJ #investivalusa #biotechnology #biopharma #medicaldevices #digitalhealth Adam Griffiths Andy Parker Cody Simmons

🚀 Life science innovators! Don’t miss our Black Friday Prize Draw—enter by 1st December for a chance to win 2 full-access passes 🎟️ and a company presentation slot 📊 at our Miami 🌴 life science investment event! ⬇️ Full details below. Good luck! 🍀